PIRAMAL ENTERPRISES Ltd | Date: 2013-03-12
The present disclosure relates to an anti-acne formulation comprising at least one active ingredient selected from the group consisting of coumarin based compounds of Formula I and Formula II; or pharmaceutically acceptable salts, polymorphs and derivatives thereof, and at least one pharmaceutically acceptable excipient. The present disclosure also relates to its application for preventing/curing/treating various acne conditions.
Sharp Corporation and Piramal Enterprises Ltd | Date: 2013-03-14
The present invention relates to compounds that are capable of inhibiting, modulating and/or regulating Insulin-Like-Growth Factor I Receptor and Insulin Receptor. The compounds of the instant invention possess a core structure that comprises a sulfonyl indole moiety. The present invention is also related to the pharmaceutically acceptable salts, hydrates and stereoisomers of these compounds.
PIRAMAL ENTERPRISES Ltd | Date: 2013-10-22
The present invention relates to a herbal composition for use in the prevention or treatment of a disease mediated by TNF-. The present invention also provides a method for the preparation of the herbal composition and methods for using such herbal composition.
PIRAMAL ENTERPRISES Ltd | Date: 2015-02-20
The present invention relates to an improved process for the preparation of 1,3,5-triazine-2,4,6(1H,3H,5H)-trione (Triglycidylisocyanurate (TGIC) or the compound of formula I) comprising reacting cyanuric acid (the compound of formula III) with 3 to 7 molar equivalents of epichlorohydrin in an autoclave at a temperature of 80-100 C. for 1 hour to give the mixture of intermediates A, B and C and reacting intermediates A, B and C with an alkali to obtain the compound of formula I.
PIRAMAL ENTERPRISES Ltd | Date: 2014-08-08
This invention relates to novel purified compounds of Formula I. The invention includes all stereoisomeric forms and all tautomeric forms of the compounds of Formula I and pharmaceutically acceptable salts and derivatives. The present invention further relates to processes for the production of the novel antibacterial compounds by fermentation of the microorganism belonging to